While almost all (6/7, 86%) patients of the KIT D816H/Ypos. cohort were diagnosed with MCL, the KITneg. subgroup included MCL (7/12, 58%) and SM-AHN (5/12, 42%) patients (Figure 1). The gene discussed is KIT; the disease is mantle cell lymphoma.